FDA Drug recall D-1421-2015
Felodipine Extended-Release Tablets, 5 mg, 100 count bottles, Rx only, Mutual Pharmaceutical Co. Inc., Philadelphia, PA --- NDC 53489-369-01
- FDA Drug
- Class III
- terminated
- Published 2015-09-16
On 2015-09-16 the FDA classified a Class III recall of Felodipine Extended-Release Tablets, 5 mg, 100 count bottles, Rx only, Mutual Pharmaceutical Co. Inc., Philadelphia, PA --- NDC 53489-369-01 by Mutual Pharmaceutical, citing chemical Contamination; benzophenone leached from the product label varnish.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1421-2015 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-07-16 |
| Published | 2015-09-16 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Mutual Pharmaceutical |
| Distribution | US |
Product
Felodipine Extended-Release Tablets, 5 mg, 100 count bottles, Rx only, Mutual Pharmaceutical Co. Inc., Philadelphia, PA --- NDC 53489-369-01
Reason
Chemical Contamination; benzophenone leached from the product label varnish
Identifiers
| code_info | lot #s: 6662801 & 6662901, exp 10/15, 6689601, exp 4/16, 6689701, exp 5/16 and 6708401, 8/16 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1421-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.